Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Today's Latest Price: $1.22 USD

0.00 (0.00%)

Updated Nov 24 4:00pm

Add CRBP to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 389 in Biotech

See all "A" rated Strong Buy stocks

Corbus Pharmaceuticals Holdings Inc (CRBP) Price Targets From Analysts

Use the tables below to see what analysts covering Corbus Pharmaceuticals Holdings Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
4 $3 $1.22 $1.88 $1.22 54.1%

CRBP Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.8 1 0 4 0 0 5

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • CRBP has a lower percent of analysts bearish on the stock than almost 100% of all US stocks.
  • Corbus Pharmaceuticals Holdings Inc's average analyst price target is higher than 2.24% of all US stocks.
  • The variance in analysts' estimates of CRBP is less than 6.59% of all US stocks.
  • Corbus Pharmaceuticals Holdings Inc's percentage of analysts bullish on the stock is higher than 6.81% of Healthcare stocks.
  • Corbus Pharmaceuticals Holdings Inc's upside potential (average analyst target price relative to current price) is greater than 77.55% of all US stocks.
  • The number of analysts covering the stock of CRBP is higher than 33.92% of Pharmaceutical Products stocks.
  • Corbus Pharmaceuticals Holdings Inc's change in bullishness amongst analysts is less than almost 100% of all US stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Corbus Pharmaceuticals Holdings Inc are PRTA, CLSD and CATB.

Make investment decisions regarding CRBP using the data that counts. Try POWR Ratings for free.



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6726 seconds.